
If you or a family member have myotonic dystrophy, the #1 thing you can do to help researchers develop an effective treatment is to enroll in the END-DM1 natural history study. Details here: clinicaltrials.gov/ct2/show/…

Focused on myotonic dystrophy type 1. My use of twitter/X is not an endorsement of the ninny who owns it. Follow me on Bluesky, dm1myotonic.bsky.social

If you or a family member have myotonic dystrophy, the #1 thing you can do to help researchers develop an effective treatment is to enroll in the END-DM1 natural history study. Details here: clinicaltrials.gov/ct2/show/…

Simulated Platform Trials May Accelerate Treatment Discovery in Myotonic Dystrophy Type 1 bioengineer.org/simulated-pl…

MDF’s new DM1 and DM2 Guides are here! 💚 We’ve reworked and expanded our previous toolkit to create guides for people living with #MyotonicDystrophy, their caregivers, and loved ones. Explore practical information about DM, medical care, and daily life.

At PepGen, we value providing the DM1 community with timely and transparent updates on our progress. Today we announced interim results from the FREEDOM2-DM1 clinical trial. Read our latest letter to the DM1 community here: pepgen.co/4iL0xTQ Thank you to those who have participated in trials, are considering participation, or supporting loved ones. Our work is not possible without you. #myotonicdystrophy #DM1

$PEPG PepGen Announces Positive Phase 2 FREEDOM2-DM1 10 mg/kg Results Demonstrating Highest Reported Splicing Correction and Improvements Across Multiple Functional Measures | PepGen investors.pepgen.com/news-re…

Dutch study: Clinical Heterogeneity in Myotonic Dystrophy Type 1: Identifying Phenotype Categories Using Unsupervised Clustering neurology.org/doi/10.1212/NX…

Greek review: Nonpharmacological and rehabilitative interventions for adults with myotonic dystrophy type 1: a systematic review ovid.com/jnls/intjrehabilres…

Dutch study: Preimplantation genetic testing in myotonic dystrophy type 1: outcomes in a nationwide Dutch cohort jnnp.bmj.com/content/early/2…

New study: Metabolomic Biomarkers of Myotonic Dystrophy taking place at Massachusetts General Hospital clinicaltrials.gov/study/NCT…

"Vertex is on track to share interim results from the GALILEO study in the second half of 2026." news.vrtx.com/news-releases/…

Norwegian study: Muscle Strength and Outcome Measures for Upper Limb Function in Adults With Myotonic Dystrophy Type 1: A Cross-Sectional Study onlinelibrary.wiley.com/doi/…

Share your thoughts on #myotonicDystrophy clinical trials with a 5-minute survey! Your feedback will help MDF understand what information is most important to the DM community as trials continue to develop. myotonicdistribution.qualtri…

NY study: Sympathetic neurons’ contribution to arrhythmias in a hiPSC-based myotonic dystrophy type 1 microphysiological system onlinelibrary.wiley.com/doi/…

Presentation by IU's Dr. Gutman: Z-Basivarsen Shows Functional Improvements in One-Year Data for Myotonic Dystrophy Type 1 youtube.com/watch?v=IdQ0b7Ja…

Dutch study: Exploring the gut microbiome in children and young adults with myotonic dystrophy type 1 journals.sagepub.com/doi/10.…
